The meeting is part of the SPARK Norway Educational Forum Series 1: Innovation and business – monthly open meetings organized by UiO:Life Science and SPARK Norway partners.
Sign up by filling out the form at the bottom of this web page.
Programme
Introduction by Anders Tuv,
Investment Director at RadForsk
-
RadForsk is an early stage Evergreen Fund dedicated to oncology, and one of the most successful pre-seed investment firms in Europe.
The fund acts as a dynamic player working in every part of the research–to–commercialization eco-system – all the way from initial research results to listing companies.
Since its establishment, RadForsk has invested in and been an active owner of more than twenty companies, and currently holds 11 companies with particular strengths in immuno-oncology. -
Tuv is also Chairman of the Board OncoImmunity, Board of Directors Zelluna Immunotherapy, Board of Directors Vaccibody, Board of Directors Nextera, Board of Directors Oslo Cancer Cluster Incubator and member of the Nomination Committee Targovax ASA.